期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 22, 页码 9914-9928出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm301113w
关键词
-
资金
- Medicen Paris Region Competitiveness Cluster [I06-222/R, I09-1739/R]
- Seine-Saint-Denis County
In this paper, we present some elements of our optimization program to decouple triclosan's specific FabI effect from. its nonspecific cytotoxic component. The implementation of this strategy delivered highly specific, potent, and nonbiocidal new FabI inhibitors. We also disclose some preclinical data of one of their representatives, 83, a novel antibacterial compound active against resistant staphylococci and some clinically, relevant Gram negative bacteria that is currently undergoing clinical trails.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据